Download Page 5 - Chitopower

32(10): 51. In Japanese. Hotta, M., Sato, Y.,
Iwata, S., Yamashjta, N., Sunakawa, K.,
Oikawa, T., Tanaka, R., Watanabe, K.,
Takayama, H. Yajuma, M., Sekiguchi, S.,
Arai, S., Sakurai, T., and Mutai, M. 1987.
Clinical
effects
.of
Bifidobacterium
preparations on pediatric intractable
diarrhea. Keio J. Med. 1987: 298-314.
Hughes, J.B., and Hoover, D.G. 1991 . Bifidobacteria: Their potential for use in
American dairy products. Food Technol.
45(4): 74, 76, 78-80, 83. Hylemon, P.B. and
Glass, T.L. 1983. Bio-transformation of bile
acids and cholesterol by the intestinal
microfiora. Chpt. 9 in Hentges (1983), pp.
189-213. Kanbe, M. 1988. Lactic acid
bacteria as physiologically functional food.
New Food Ind. 30(1): 77-87. In Japanese.
Kanbe, M. 1992a. Uses of intestinal lactic
acid bacteria and health. Chpt. 13 in
Nakazawa and Hosono (1992), p. 300. Kanbe,
M. 1992b. Cancer control and fermented
milk. Chpt. 17 in Nakazawa and Hosono, p.
377.
Kato, Y., Shirayanagi, S., Mizutani, J., and
Hayakawa, K. 1992. The effects of soybean
oligosaccharides on intestinal metabolic
activity. Personal communication, Soya
Oligo Japan Co. R&D Center, Tokyo. In
Japanese.
Kohwi,
Y., Imai, K., Tamura, Z., and
Hashimoto, Y. 1978. Antitumor effect of
Bifidobacterium infantis in mice. Gann
(Cancer) 69: 613-618.
Kohwi, Y., Hashimoto, J., and Tamura, Z.
1982. Antitumor and immunological adjuvant
effect of Bifidoba.cteriu.rn infantis in mice.
Bifidobacteria Microflora 1(1): 61-68.
Koizumi, T., Mituya, N., Mukuta, T., Fujita,
S., Ishiau, H-., and Yoshioka, H. 1980. Effects
of administration of Bifidobacterium
preparation (BBG-02) on hepatic coma.
Sogo Rinsho (Total Clinics) 29: 2473-2478. In
Japanese.
Komai, M. 1990. Intestinal microfiora and
health. New Food Ind. 32(12): 39-50. In
Japanese.
Komai, M. and Nanno, M. 1992. Intestinal
microfiora and longevity. Chpt. 15 in
Nakazawa and Hosono, p. 325. Kurmann,
J.A. and Rasic, J.Lj. 1991. The health
potential
of
products
containing
bi-fidobacteria. Chpt. 6 in "Therapeutic Properties of Fermented Milk," ed. R.K.
Robinson, p. 117. Elsevier Applied Science
Publishing Co., Inc., New York. Mann. G.V.
and Spoerry, A. 1974. Studies of a surfactant
and cholesteremia in the Masai. Am. J.
Clin. Nutr. 27: 464. Masai, T., Wada, K.,
Hayakawa, K., Yoshihara, I., and Mitsuoka,
T. 1987. Effects of soybean oligosaccharides
on human intestinal flora and metabolic
activities. Japan. J. Bacteriol. 42(1): 313.
Mata, L.J., Carillo, C., and Villatoro, E.
1969. Fecal microfiora in healthy persons in a
preindustnal region. Appl. Microbiol. 17:
596-602.
Matsunami, T., Mochizuki, N., and Masai, T.
1992. The effects of a soybean
oligosaccha-rides-containing soft drink on
defecation and gastrointestinal conditions.
Personal communication, Soya Oligo
Japan Co., R&D Center. In Japanese.
Mitsuoka, T. 1982. Recent trends in research
on intestinal flora. Bifidobacteria Microflora 1(1): 3-24.
Mitsuoka, T. 1990a. "Tales of Intestinal
Microflora." Iwanami Shoten Publisher,
Tokyo. In Japanese.
Mitsuoka, T. 1990b. Health and intestinal
microflora. New Food Ind. 32(10): 1. In
Japanese.
Mitsuoka, T. 1990c. Bifidobacteria and their
role in human health. J. Ind. Microbiol. 6:
263-267.
Mizutaru, T. 1992. The relationship between
microorganisms and the physiology of
aging. Chpt. 14 in Nakazawa and Hosono, p.
305.
Murphy, E.L., Horsiey, H., and Burr, H.K.
1972. Fractionation of dry bean extracts
whjch increase carbon dioxide egestion in
human flatus. J. Agric. Food Chem. 20:
813.
Mutai, M. 1978. Characteristics of "Mil-Mil," a
Bifidobacterium fermented milk. New
Food Ind. 20(8): 17. In Japanese. Muting, D.,
Escherich, D., and Mayer, J. P. 1968. The
effect of Bifidobacterium bifi-dam on
intestinal bacterial flora and toxic protein
metabolites in chronic liver diseases. Am. J.
Proctol. 19: 336-342. Nakaya, R. 1984. Role
of Bifidobacterium in enteric infection.
Bifidobacteria Microflora 3: 3-9.
Nakazawa, Y. and Hosono, A. 1992. "Functions of Fermented Milk." Elsevier Applied
Science, New York.
Nowak, J. and Steinkraus, K.H. 1988. Effect
of tempeh fermentation of peas on their
potential flatulence productivity as measured by gas production and growth of
Clostridium perfringens. Nutr. Repts. Intl.
38: 1163-1171.
Okamura, N., Nakaya, R., Yokota, H., Yanai,
N., and Kawashima, T. 1986. Interaction of
Shigelta with Bifidobacteria. Bifidobacteria
Microflora 5: 51-55. Orla-Jensen, S., Olsen, E.,
and Geill, T. 1945. Senility and intestinal
flora. Kgl. Danske Vidensk. Selskab. Biol.
Skifter 3: 3-38. Quaker Oats Co. 1993.
Internal report D93077. Unpublished. Barrington, 111. Rasic, J.
and Kurmann, J. 1983. Nutritive and health
values
of
dairy
foods
containing
bifidobacteria. Chpt. 6 in "Bifidobacteria
and Their Role," pp. 81-101. Birkhauser
Verlag Basel, Basel, Switzerland. Reddy,
N.R., Pierson, M.D., Sathe, S.K., and
Salunkhe, D.K. 1984. Chemical, nutritional
and physiological aspects of dry bean
carbohydrates—A review. Food Chem. 13: 48.
Renner, H.W. and Munzner, R. 1991. The
possible role of prebiotics as dietary
antimutagens. Mutagen Res. 262: 239-245.
Roberts, A.K., van Biervliet, J.P., and
Harzer, G. 1985. Factors of human milk
influencing the bacterial flora of infant
faeces. In "Composition and Physiological
Properties of Human Milk," ed. J. Schaub, pp.
259-269. Elsevier, Amsterdam. Saito, Y.,
Takano, T., and Rowland, I. 1992. Effects of
soybean oligosaccharides on the human gut
microflora in in vitro culture. Microbial
Ecol. Health Dis. 5: 105-111. Spiegel, J.E.,
Tose, R., Karabell, P., Frankos, V.H., and
Schmitt, D.F. 1994. Safety and benefits of
fructooligosaccharides as food
ingredients. Food Technol. 48(1): 85-89.
Suzuki, K. 1985. Intestinal microflora and
carcinogenesis. Biseibutsu (Microbes) 1(4): 12.
In Japanese.
Suzuki, Y., Kaizu, H., and Yamaguchi, Y.
1991. Effect of cultured milk on serum cholesterol concentrations in rats fed
high-choiesterol diets. Animal Sci. Technol.
(Japan) 62(6): 565-571. In Japanese.
Takasoye, M., Inoue, N., and Knuma, C.
1990. Clinical investigation of feces improvements by soybean oligosaccharides.
Rinsho toh Kenkyu 'Clinics and Research) 67:
304—310. In Japanese. Taketomo, T., Oda,
M., Oyama, K., Kanbe, M., and Tsuchiya, F.
1983.
A
high
molecular
weight
polysaccharide MPS-82 and its application.
Japan Kokai Tokkyo Koho (Japanese
Patent Publication), Sho 58-203913. In
Japanese.
Tamura, Z. 1983. Nu-.riology of bifidobacteria.
Bifidobacteria Microflora 2(1): 3-16.
Tannenbaum, S.R. 1979. Endogenous formation of nitrite and N-nitroso compounds.
Proc. EX Intl. Symp. Princess Takamatsu
Cancer Res. Fund. Tokyo, pp. 211-220.
Tokunaga, T., Oku, T., and Hosoya, N. 1986.
Influence of chronic intake of new sweetener
fructooligosaccharide (Neosugar) on growth
and gastrointestinal function of the rat. J.
Nutr. Sci. Vitaminol. 32: 111-121. Wada, K,
Watabe, J., Mizutani, J., Suzuki, H., Kiriu,
N., Hayakawa, K., and Yamaguchi, C. 1991.
Effects of soybean oligosaccharides intake on
fecal microflora, enzyme activity, ammonia
and frequency of evacuation in elderly
persons. Bifidus 4: 135-140. In Japanese.
Wagner, J.R., Carson, J.F., Becker, R.,
Gumbmann, M.R., and Danhof, I.E. 1977.
Comparative flatulence activity of beans
and bean fractions for man and rat. J. Nutr.
107: 680.
Wilkins, T.D. and Van Tassel, R.L. 1983a.
Production of intestinal mutagens. Chpt. 12
in Hentges (1983), p. 265. Wilkins, T.D. and
Van Tassel, R.L. 1983b. Production of
intestinal mutagens. Chpt. 12 in Hentges
(1983), p. 272. Yasuda, H., Hisamatsu, M.,
Adachi, G., Niwa, T., and Sekizawa, T.
1981.
Anti-tumor
immune-activator
EES-163S obtained by culturing bacteria
of genus Bifidobacterium. Japan Kokai
Tokkyo
Koho
(Japanese
Patent
Publication), Sho 56-58491. In Japanese.
Yasuda, H., Adachi, G., Takizawa, T., and
Uchida, S. 1983. Antitumor substance and the
method of preparation. Japan Kokai
Tokkyo Koho (Japanese Patent Publication),
Sho 56-103194. In Japanese.
The author acknowledges the assistance
of Geraidine Horton, Head Librarian,
Quaker Oats Co.
For a copy of tables briefly summarizing
the literature on effect of oligosaccharide
intake on (a) changes in levels of bifidobacteria and other bacteria, (b) reduction of
toxic metabolites and detrimental enzymes
in the intestine, (c) constipation, and (d)
serum cholesterol reduction, contact the
author.
—Edited by Neil H. Mermelstein, Senior
Associate Editor
OCTOBER 1994—FOOD TECHNOLOGY
65